Objectives Women with recurrent high-grade neuroendocrine cervical cancer have few
effective treatment options. The aim of this study was to identify potential therapeutic targets …

Objective To compare discharge opioid refills, prescribed morphine equivalent dose and
quantity, and longitudinal patient-reported outcomes before and after implementation of a …

Background Opioid over-prescription is wasteful and contributes to the opioid crisis. We
implemented a personalized tiered discharge opioid protocol and education on opioid …

Objective: There is considerable interobserver variability in the differential diagnosis
between ovarian high-grade endometrioid carcinoma (HGEC) and ovarian high-grade …

5567 Background: The FDA has separately approved pembrolizumab for all advanced solid
tumors with either microsatellite instability or high tumor mutational burden (≥ 10 mutations …

5509 Background: Resistance to platinum-based chemotherapy is a major cause of disease
progression and mortality among women with high grade serous ovarian cancer (HGSOC). It …

5573 Background: Adult-type granulosa cell tumor of the ovary (aGCT) is a rare tumor that
often relapses and the optimal management strategy is not known. Cytoreductive surgery …

5611 Background: We aimed to describe RAS mutations in gynecologic cancers as they
relate to clinicopathologic features, subtypes, co-mutations, and implications for therapy …

Background: Adult-type granulosa cell tumors (aGCTs) are a rare monogenic disease.
Nearly all aGCTs carry a missense point mutation in the Forkhead domain containing …

5549 Background: Cure rates for patients with advanced stage ovarian cancer have not
changed over the last four decades likely due to inability to eradicate residual cancer cells …